ID 205291398 · FY 2018–2020 · 3 years
Maxpharma (მაქსფარმა) — a small Georgian pharmaceutical company (revenue ~GEL 2–3m, thin gross margin ~9–12%, asset-light) classified as wholesale/distribution by inference; no financial filings after FY2020, so likely dormant. No public presence.
curated 2026-06-25
| Line item | 2018 | 2019 | 2020 | CAGR |
|---|---|---|---|---|
| Total Revenue | 3,225 | 2,563 | 1,840 | -24.5% |
| Total COGS | -2,933 | -2,327 | -1,618 | -25.7% |
| Gross Profit | 292 | 236 | 222 | -12.8% |
| Gross Margin | 9.0% | 9.2% | 12.1% | |
| Total Operating Expenses | -342 | -323 | -289 | -8.1% |
| EBITDA | -50 | -87 | -67 | +15.4% |
| EBITDA Margin | -1.6% | -3.4% | -3.7% | |
| Total D&A | -8 | -7 | -6 | -9.3% |
| EBIT / Operating Income | -58 | -94 | -73 | +12.5% |
| Total Other Income | 0 | 14 | 19 | +27.9% |
| Profit Before Tax | -58 | -80 | -55 | -2.7% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | -50 | -87 | -67 | +15.4% |
| Net Margin | -1.6% | -3.4% | -3.7% |
Ownership & directors from companyinfo.ge (public corporate registry).